- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03317587
Inspiring Nutritious Selections and Positive Intentions Regarding Eating and Exercise (INSPIRE)
December 20, 2017 updated by: Virginia Commonwealth University
The aims of the current study are: 1) to pilot a manualized intervention (INSPIRE - Inspiring Nutritious Selections and Positive Intentions Regarding Eating and Exercise) to determine feasibility and acceptability, and 2) to evaluate the preliminary effectiveness of INSPIRE on physical and psychological variables.
Study Overview
Detailed Description
The purpose of the current study is to implement an evidence-based prevention program to promote positive health behaviors among young adult women.
It will be one of the first to intentionally execute a prevention program targeting well-established risk factors for both obesity and eating disorders in this high-risk population.
Intervention content focuses on promoting body size diversity and emphasizing positive health and behavior change in order to reduce stigmatization and remain sensitive to weight-related issues.
The manual was developed by integrating two successful existing prevention programs and expanding on previous prevention efforts.
Specifically, the diversity of beauty ideals were highlighted to enhance relevance among ethnic minority women, and distress tolerance and emotion regulation skills training were included to target the maladaptive coping mechanisms young adults use to manage the stress associated with transitioning to college.
Study Type
Interventional
Enrollment (Actual)
29
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Virginia
-
Richmond, Virginia, United States, 23298
- Virginia Commonwealth University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 25 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Currently enrolled in postsecondary education at Virginia Commonwealth University
Exclusion Criteria:
- BMI ≥ 30 kg/m2
- Meet criteria for eating disorder threshold risk
- Pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: INSPIRE
|
Eight week program of weekly group sessions with homework assignments addressing beauty ideals, establishing a healthy relationship with food and exercise, and tolerating and managing uncomfortable emotions.
Participants will complete questionnaires are separate time points (one week before the program, one week after the program, and 1 month after the program) to evaluate the impact of the program on various behavioral and psychological outcomes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acceptability of intervention
Time Frame: 8 weeks
|
Acceptability of the intervention will be assessed via aggregation of the ordinal-level items on the weekly participation satisfaction surveys.
|
8 weeks
|
|
Feasibility of the intervention
Time Frame: 8 weeks
|
Feasibility of the intervention will be assessed via aggregation of the ordinal-level items on the weekly therapist feasibility surveys.
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Eating disorder behaviors
Time Frame: Baseline to 14 weeks
|
Change in disordered eating behaviors will be assessed with the Eating Disorder Examination Questionnaire.
Participants will complete this one week before the program, one week after the program, and one month after the program.
|
Baseline to 14 weeks
|
|
Risk for obesity (BMI)
Time Frame: Baseline to 14 weeks
|
Weight will be measured (by trained staff) to the nearest ¼ kg using a digital scale and height will be measured to the nearest cm using a stadiometer; these measurements will be used to calculate BMI (kg/m2).
Measurements will be taken one week before the program, one week after the program, and one month after the program.
|
Baseline to 14 weeks
|
|
Appearance Ideals
Time Frame: Baseline to14 weeks
|
Changes in appearance ideals will be evaluated with the Body Image-Ideals Questionnaire, a self-report questionnaire that quantifies an individual's perceived discrepancy from and importance of internalized ideals for multiple physical attributes.
Participants will complete this one week before the program, one week after the program, and one month after the program.
|
Baseline to14 weeks
|
|
Emotion Regulation Difficulties
Time Frame: Baseline to14 weeks
|
Changes in difficulty regulating emotions and tolerating distress will be assessed with the Difficulties in Emotion Regulation Scale.
Participants will complete this one week before the program, one week after the program, and one month after the program.
|
Baseline to14 weeks
|
|
Healthy Eating
Time Frame: Baseline to14 weeks
|
Change in dietary intake will be assessed using the Block Food Screener, a self-report questionnaire that surveys the leading sources of fat, fiber, fruits, and vegetables in the diets of North Americans.
Participants will complete this one week before the program, one week after the program, and one month after the program.
|
Baseline to14 weeks
|
|
Physical Activity
Time Frame: Baseline to14 weeks
|
Change in physical activity during the past seven days will be assessed with the Seven-Day Physical Activity Recall.
This measures the frequency and duration of each physical activity performed throughout the day.
Participants will complete this one week before the program, one week after the program, and one month after the program.
|
Baseline to14 weeks
|
|
Thin-ideal internalization
Time Frame: Baseline to14 weeks
|
Change in thin-ideal internalization will be assessed with the Ideal-Body Stereotype Scale - Revised.
Participants will complete this one week before the program, one week after the program, and one month after the program.
|
Baseline to14 weeks
|
|
Negative Affect
Time Frame: Baseline to14 weeks
|
Change in negative affect will be assessed using the sadness, guilt, hostility, and fear/anxiety subscales of the Positive and Negative Affect Scale - Revised.
Participants will complete the this one week before the program, one week after the program, and one month after the program.
|
Baseline to14 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 5, 2017
Primary Completion (Actual)
December 8, 2017
Study Completion (Actual)
December 8, 2017
Study Registration Dates
First Submitted
September 27, 2017
First Submitted That Met QC Criteria
October 20, 2017
First Posted (Actual)
October 23, 2017
Study Record Updates
Last Update Posted (Actual)
December 22, 2017
Last Update Submitted That Met QC Criteria
December 20, 2017
Last Verified
December 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HM20011075
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on INSPIRE
-
Inspire Medical Systems, Inc.CompletedObstructive Sleep ApneaUnited States, Germany, Belgium, France, Netherlands
-
University Hospital, AntwerpRecruitingApnea | Obstructive Sleep Apnea | Sleep ApneaBelgium
-
University of BernNot yet recruitingBurnout, Professional | Emotions | Satisfaction, Personal | Wellness, Psychological | Emotional ExhaustionSwitzerland
-
Inspire Medical Systems, Inc.Active, not recruiting
-
Inspire Medical Systems, Inc.Terminated
-
Inspire Medical Systems, Inc.CompletedObstructive Sleep ApneaGermany
-
St. Justine's HospitalCompletedStress | Virtual Reality | Stress, Work PlaceCanada
-
University of ManchesterCompleted
-
Inspire Medical Systems, Inc.RecruitingObstructive Sleep Apnea | Obstructive Sleep Apnea (OSA)United Kingdom, Belgium, France, Germany, Austria, Netherlands, Switzerland
-
University of Alabama at BirminghamOhio State University; American Heart Association; Tuskegee UniversityRecruitingCardiovascular Diseases | Smoking | Hypertension | Obesity | Diabetes | Hyperlipidemia | Kidney Disease | Cardiovascular-kidney-metabolic SyndromeUnited States